A-76: When Biomarkers and Cognition Disagree: Clinical Implications of Amyloid Positivity Without Cognitive Impairment
Objective: Advances in amyloid biomarkers, including positron emission tomography and cerebrospinal fluid or blood-based assays, have made it possible to detect Alzheimer’s disease pathology earlier. However, there are increasing cases in which biomarker positivity does not align with neuropsychological findings. Pat...